EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical characteristics and prognostic factors in non-HIV patients with Pneumocystis jirovecii pneumonia and BALF cytomegalovirus co-detection: a retrospective cohort study

Chaomin Guo, Yajiao An, Jingyun Ye, Yanning Ma, Qiang Zhao, Lifeng Wang, Wei Ma, Mingze Zhang, Miaoyu Wang, Yang Wang, Jiyong Yang, Liyan Ye und 1 weitere

Frontiers in Public Health · 2026

DOI: 10.3389/fpubh.2026.1921801 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von Chaomin Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Department, The First Medical Center, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Bronchoalveolar Lavage Fluid, Pneumocystis carinii, Cytomegalovirus Infections. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pneumocystis jirovecii pneumonia (PJP) is a life-threatening opportunistic infection in immunocompromised patients. BALF cytomegalovirus (CMV) co-detection is frequently observed in PJP patients, but its clinical characteristics and prognostic impact in non-HIV populations remain unclear.

Methods

In this single-center retrospective cohort study, we enrolled 62 non-HIV patients with confirmed PJP between 2019 and 2023. BALF CMV co-detection was defined as detectable CMV DNA in bronchoalveolar lavage fluid via metagenomic next-generation sequencing (mNGS), combined with compatible respiratory symptoms and chest computed tomography abnormalities. The Benjamini–Hochberg false discovery rate (FDR) correction was applied for multiple comparisons.

Results

Overall, 31 patients (50.0%) had BALF CMV co-detection. The 28-day all-cause mortality was significantly higher in the CMV co-detection group than in the PJP-only group (54.84% vs. 19.35%, p = 0.008), and dyspnea was more prevalent ( p = 0.024). After FDR correction for 39 laboratory parameters, only fibrinogen remained significantly lower in the co-detection group ( q = 0.039), while (1,3)-β-D-glucan (BDG) and D-dimer showed independent associations with CMV co-detection in multivariable analyses. mNGS revealed more concurrent viral and fungal pathogens in the co-detection group, and multiple co-pathogens were more frequent in non-survivors within this subgroup. Interleukin-6 (IL-6), procalcitonin (PCT) and D-dimer were identified as independent prognostic factors for 28-day mortality in the CMV co-detection subgroup.

Conclusion

In this single-center retrospective cohort, BALF CMV co-detection is associated with substantially elevated unadjusted 28-day mortality in non-HIV patients with PJP. These findings are hypothesis-generating; IL-6, PCT and D-dimer show potential as exploratory prognostic markers. Comprehensive mNGS-based pathogen screening combined with biomarker monitoring may facilitate risk stratification in this high-risk population, pending validation in larger prospective cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisBronchoalveolar Lavage FluidPneumocystis cariniiCytomegalovirus InfectionsCytomegalovirusCoinfectionHumansRetrospective StudiesPrognosisMaleFemaleMiddle Aged

Stichwörter der Autor:innen

Pneumocystis jirovecii pneumoniaco-detectioncytomegalovirusmetagenomic next-generation sequencingnon-HIV immunocompromised patientsprognostic biomarkersretrospective cohort study

Autor:innen und Institutionen

  • Laboratory Medicine Department, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Laboratory Medicine Department, Cengong County People's Hospital, Guizhou, China.
  • Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Pulmonary and Critical Care Medicine, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
  • Laboratory Medicine Department, Hainan Branch, Chinese PLA General Hospital, Sanya, Hainan, China.

Zitieren

APA

Guo, C., An, Y., Ye, J., Ma, Y., Zhao, Q., Wang, L., Ma, W., Zhang, M., Wang, M., Wang, Y., Yang, J., Ye, L., & Yang, L. (2026). Clinical characteristics and prognostic factors in non-HIV patients with Pneumocystis jirovecii pneumonia and BALF cytomegalovirus co-detection: a retrospective cohort study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1921801

Vancouver

Guo C, An Y, Ye J, Ma Y, Zhao Q, Wang L, et al. Clinical characteristics and prognostic factors in non-HIV patients with Pneumocystis jirovecii pneumonia and BALF cytomegalovirus co-detection: a retrospective cohort study. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1921801

BibTeX
@article{Guo2026,
  author = {Guo, Chaomin and An, Yajiao and Ye, Jingyun and Ma, Yanning and Zhao, Qiang and Wang, Lifeng and Ma, Wei and Zhang, Mingze and Wang, Miaoyu and Wang, Yang and Yang, Jiyong and Ye, Liyan and Yang, Liuyang},
  title = {Clinical characteristics and prognostic factors in non-HIV patients with Pneumocystis jirovecii pneumonia and BALF cytomegalovirus co-detection: a retrospective cohort study},
  journal = {Frontiers in Public Health},
  year = {2026},
  doi = {10.3389/fpubh.2026.1921801}
}
Kostenlos starten →